Literature DB >> 21547904

Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community.

Xianghong Zhang1, Liying Xue, Lingxiao Xing, Junling Wang, Jinfeng Cui, Jianmin Mi, Xin Xing, Juan Wang, Zhanjun Du, Junichi Misumi, Qingbao Tian, Liqin Wang.   

Abstract

The correlation between low serum PG level and H. pylori infection with the development of gastric cancer has caused considerable concerns all over the world. Some authors exclaimed that gastric cancer developed only in patients infected with H. pylori, whereas the other had different findings. In this study, 1,501 adult local residents with determined serum PG levels and anti H. pylori IgG status were followed for 14 years for the development of gastric cancer in a rural community with high risk of gastric cancer in Hebei Province, China. The results showed the accumulated gastric cancer incidence in the subjects with abnormal PG level and those with H. pylori infection were all significantly higher than that in the corresponding normal controls (53.9‰ vs. 12.7‰, p < 0.05 and 23.1‰ vs. 5.93‰, p < 0.05). The highest gastric cancer incidence was seen in the subjects with both abnormal serum PG and positive H. pylori (56.0‰), and followed by the subjects with abnormal PG and negative H. pylori (47.6‰) and those with normal serum PG and positive H. pylori (18.4‰). The abnormal serum PG level (OR 3.029) and H. pylori infection (OR 4.345) were all risk factors for the development of gastric cancer. The results suggested that the subjects with abnormal serum PG level and/or positive H. pylori infection in the rural area of China were all high risk population for gastric carcinoma and the subjects with both abnormal serum PG and positive H. pylori infection were at especially high risk for the development of gastric carcinoma.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547904     DOI: 10.1002/ijc.26172

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  Helicobacter pylori infection and pepsinogen levels have clinical significance in hypertension patients.

Authors:  Changqing Lu; Helei Jia; Aiguo Xu; Jianming Tang; Gang Xu; Wenbin Yue; Junjie Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China.

Authors:  J Jiang; Y Chen; J Shi; C Song; J Zhang; K Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-22       Impact factor: 3.267

Review 3.  Biomarkers of Helicobacter pylori-associated gastric cancer.

Authors:  Cara L Cooke; Javier Torres; Jay V Solnick
Journal:  Gut Microbes       Date:  2013-07-12

4.  Serum pepsinogen II is a better diagnostic marker in gastric cancer.

Authors:  Xue-Yuan Cao; Zhi-Fang Jia; Mei-Shan Jin; Dong-Hui Cao; Fei Kong; Jian Suo; Jing Jiang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

5.  Comparative analysis of upper gastrointestinal endoscopy, double-contrast upper gastrointestinal barium X-ray radiography, and the titer of serum anti-Helicobacter pylori IgG focusing on the diagnosis of atrophic gastritis.

Authors:  Nobutake Yamamichi; Chigaya Hirano; Yu Takahashi; Chihiro Minatsuki; Chiemi Nakayama; Rie Matsuda; Takeshi Shimamoto; Chihiro Takeuchi; Shinya Kodashima; Satoshi Ono; Yosuke Tsuji; Mitsuhiro Fujishiro; Ryoichi Wada; Toru Mitsushima; Kazuhiko Koike
Journal:  Gastric Cancer       Date:  2015-07-30       Impact factor: 7.370

6.  Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.

Authors:  Huakang Tu; Liping Sun; Xiao Dong; Yuehua Gong; Qian Xu; Jingjing Jing; Qi Long; W Dana Flanders; Roberd M Bostick; Yuan Yuan
Journal:  Int J Cancer       Date:  2014-06-19       Impact factor: 7.396

7.  Serological assessment of gastric mucosal atrophy in gastric cancer.

Authors:  Jan Bornschein; Michael Selgrad; Thomas Wex; Doerthe Kuester; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2012-01-31       Impact factor: 3.067

8.  A survey and evaluation of population-based screening for gastric cancer.

Authors:  Yuan Yuan
Journal:  Cancer Biol Med       Date:  2013-06       Impact factor: 4.248

Review 9.  Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis.

Authors:  Teruhiko Terasawa; Hiroshi Nishida; Katsuaki Kato; Isao Miyashiro; Takaki Yoshikawa; Reo Takaku; Chisato Hamashima
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

10.  Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects.

Authors:  Hong Yu; Ying Liu; Shujing Jiang; Yunfeng Zhou; Zheng Guan; Siyuan Dong; Fong-Fong Chu; Chunbo Kang; Qiang Gao
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.